Search


 
Results 1 - 5 of about 5 for "FDA update".

Regorafenib now FDA-approved to treat hepatocellular ...

Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.

IBS-D drug should not be prescribed to patients without ...

The FDA suggests that clinicians should consider alternatives to eluxadoline in this population.

New drug approved for carcinoid syndrome diarrhea | ACP ...

The drug reduces the frequency of diarrhea by inhibiting the production of serotonin by carcinoid tumors.

Generic form of mesalamine approved | ACP ...

The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.

Drug for chronic idiopathic constipation approved | ACP ...

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.